107 related articles for article (PubMed ID: 12014448)
1. UK-2A, B, C, and D, novel antifungal antibiotics from Streptomyces sp. 517-02 VII. Membrane injury induced by C9-UK-2A, a derivative of UK-2A, in Rhodotorula mucilaginosa IFO 0001.
Tani K; Usuki Y; Motoba K; Fujita K; Taniguchi M
J Antibiot (Tokyo); 2002 Mar; 55(3):315-21. PubMed ID: 12014448
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition dependent on reactive oxygen species generated by C9-UK-2A, a derivative of the antifungal antibiotic UK-2A, in Saccharomyces cerevisiae.
Fujita K; Tani K; Usuki Y; Tanaka T; Taniguchi M
J Antibiot (Tokyo); 2004 Aug; 57(8):511-7. PubMed ID: 15515888
[TBL] [Abstract][Full Text] [Related]
3. UK-2A, B, C, and D, novel antifungal antibiotics from Streptomyces sp. 517-02. VIII. Reactive oxygen species generated by C9-UK-2A, a derivative of UK-2A, in Rhodotorula mucilaginosa IFO 0001.
Tani K; Usuki Y; Fujita K; Taniguchi M
J Antibiot (Tokyo); 2003 Mar; 56(3):314-7. PubMed ID: 12760689
[No Abstract] [Full Text] [Related]
4. Structure-activity relationship studies on UK-2A, a novel antifungal antibiotic from Streptomyces sp. 517-02. Part 5: Roles of the 9-membered dilactone-ring moiety in respiratory inhibition.
Usuki Y; Adachi N; Fujita K; Ichimura A; Iio H; Taniguchi M
Bioorg Med Chem Lett; 2006 Jun; 16(12):3319-22. PubMed ID: 16564168
[TBL] [Abstract][Full Text] [Related]
5. UK-2A, B, C and D, novel antifungal antibiotics from streptomyces sp. 517-02 VI (3). Role of substituents on dilactone ring of UK-2A and antimycin A3 against generation of reactive oxygen species in porcine renal proximal tubule LLC-PK1 cells.
Fujita K; Kiso T; Usuki Y; Tanaka T; Taniguchi M
J Antibiot (Tokyo); 2004 Oct; 57(10):687-90. PubMed ID: 15638330
[No Abstract] [Full Text] [Related]
6. UK-3A, a novel antifungal antibiotic from Streptomyces sp. 517-02: fermentation, isolation, structural elucidation and biological properties.
Ueki M; Kusumoto A; Hanafi M; Shibata K; Tanaka T; Taniguchi M
J Antibiot (Tokyo); 1997 Jul; 50(7):551-5. PubMed ID: 9711246
[TBL] [Abstract][Full Text] [Related]
7. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. VI(1). Structure-activity relationships of UK-2A.
Usuki Y; Tani K; Fujita K; Taniguchi M
J Antibiot (Tokyo); 2001 Jul; 54(7):600-2. PubMed ID: 11560380
[No Abstract] [Full Text] [Related]
8. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. IV. Comparative studies of UK-2A with antimycin A3 on cytotoxic activity and reactive oxygen species generation in LLC-PK1 cells.
Takimoto H; Machida K; Ueki M; Tanaka T; Taniguchi M
J Antibiot (Tokyo); 1999 May; 52(5):480-4. PubMed ID: 10480572
[TBL] [Abstract][Full Text] [Related]
9. UK-2A,B,C and D, novel antifungal antibiotics from Streptomyces sp.517.02. V. Inhibition mechanism of bovine heart mitochondrial cytochrome bc1 by the novel antibiotic UK-2A.
Machida K; Takimoto H; Miyoshi H; Taniguchi M
J Antibiot (Tokyo); 1999 Aug; 52(8):748-53. PubMed ID: 10580388
[TBL] [Abstract][Full Text] [Related]
10. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. I. Fermentation, isolation, and biological properties.
Ueki M; Abe K; Hanafi M; Shibata K; Tanaka T; Taniguchi M
J Antibiot (Tokyo); 1996 Jul; 49(7):639-43. PubMed ID: 8784423
[TBL] [Abstract][Full Text] [Related]
11. Semi-synthesis and biological evaluation of analogues of UK-2A, a novel antifungal antibiotic from Streptomyces sp. 517-02.
Usuki Y; Mitomo K; Adachi N; Ping X; Fujita K; Sakanaka O; Iinuma K; Iio H; Taniguchi M
Bioorg Med Chem Lett; 2005 Apr; 15(8):2011-4. PubMed ID: 15808458
[TBL] [Abstract][Full Text] [Related]
12. The mode of action of UK-2A and UK-3A, novel antifungal antibiotics from Streptomyces sp. 517-02.
Ueki M; Taniguchi M
J Antibiot (Tokyo); 1997 Dec; 50(12):1052-7. PubMed ID: 9510913
[TBL] [Abstract][Full Text] [Related]
13. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. II. Structural elucidation.
Hanafi M; Shibata K; Ueki M; Taniguchi M
J Antibiot (Tokyo); 1996 Dec; 49(12):1226-31. PubMed ID: 9031668
[TBL] [Abstract][Full Text] [Related]
14. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02 VI (2). Structure-activity relationships of UK-2A.
Usuki Y; Goto K; Kiso T; Tani K; Ping X; Fujita K; Iio H; Taniguchi M
J Antibiot (Tokyo); 2002 Jun; 55(6):607-10. PubMed ID: 12195970
[No Abstract] [Full Text] [Related]
15. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. III. Absolute configuration of an antifungal antibiotic, UK-2A, and consideration of its conformation.
Shibata K; Hanafi M; Fujii J; Sakanaka O; Iinuma K; Ueki M; Taniguchi M
J Antibiot (Tokyo); 1998 Dec; 51(12):1113-6. PubMed ID: 10048572
[No Abstract] [Full Text] [Related]
16. Synthesis and biological activity of analogs of the antifungal antibiotic UK-2A. II. Impact of modifications to the macrocycle benzyl position.
Owen WJ; Meyer KG; Meyer ST; Li F; Slanec TJ; Wang NX; Yao C
Pest Manag Sci; 2019 Jul; 75(7):1831-1846. PubMed ID: 30636031
[TBL] [Abstract][Full Text] [Related]
17. UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. IV. Antifungal action of methyl UK-1.
Ueki M; Shibata K; Taniguchi M
J Antibiot (Tokyo); 1998 Sep; 51(9):883-5. PubMed ID: 9820240
[No Abstract] [Full Text] [Related]
18. Synthesis and biological activity of analogs of the antifungal antibiotic UK-2A. I. Impact of picolinamide ring replacement.
Owen WJ; Meyer KG; Slanec TJ; Wang NX; Meyer ST; Niyaz NM; Rogers RB; Bravo-Altamirano K; Herrick JL; Yao C
Pest Manag Sci; 2019 Feb; 75(2):413-426. PubMed ID: 29952118
[TBL] [Abstract][Full Text] [Related]
19. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital.
Falces-Romero I; Cendejas-Bueno E; Romero-Gómez MP; García-Rodríguez J
Mycoses; 2018 Jan; 61(1):35-39. PubMed ID: 28922488
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Interactions of Amphotericin B Combined with Non-antifungal Agents Against Rhodotorula mucilaginosa Strains.
Spader TB; Ramírez-Castrillón M; Valente P; Alves SH; Severo LC
Mycopathologia; 2019 Feb; 184(1):35-43. PubMed ID: 30632048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
